Coronavirus News Roundup: Moderna Increases Production Estimates for COVID-19 Vaccine, FDA Warns Against Changes to Vaccine Dosing Schedules

The number of coronavirus disease 2019 (COVID-19) cases in the United States continue to surge, with a weekly average of 266,000 daily cases and an estimated 132,000 COVID-19––related hospitalizations as of January 7, according to The COVID Tracking Project.

Here’s a roundup of the latest coronavirus-related news:

IDSA Releases Revised Guidelines for COVID-19 Diagnostic Testing

In a briefing on Wednesday, Infectious Diseases Society of America (IDSA) board of directors members discussed revised recommendations for COVID-19 diagnostic testing.

Read more

Moderna Increases Production Estimates for COVID-19 Vaccine

Moderna is increasing the estimated number of doses of its COVID-19 vaccine that it expects to produce to 600 million for 2021, according to a company statement.

Read more

FDA Warns Against Changes to Authorized Dosing Schedules of COVID-19 Vaccines

Officials with the FDA took a stance on the authorized dosing schedules for COVID-19 vaccines, stating that all health care professionals should continue to administer 2 full doses of the vaccine, according to a statement.

Read more

Novavax Announces Phase 3 Study for COVID-19 Vaccine Candidate

Biotechnology company Novavax has announced the start of its phase 3 study evaluating a vaccine candidate for COVID-19.

Read more

Addressing SDoH, COVID-19 Vaccine at BCBS Minnesota

In this final part of a 3-part video series, Craig Samitt, CEO and president of Blue Cross Blue Shield of Minnesota talks with Managed Healthcare Executive about their focus on social determinants of health and the COVID-19 vaccine.

Read more on Managed Healthcare Executive